Similar articles for PMID: 17305414

Year	Number of Results
1999	1
2001	1
2002	3
2003	14
2004	21
2005	30
2006	20
2007	15
2008	9
2009	14
2010	11
2011	10
2012	9
2013	8
2014	4
2015	1
2016	7
2017	5
2018	6
2019	7
2020	5
2021	7
2022	5
2023	1
2024	0

1

Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.

Domínguez-Gil A, Martín I, García Vargas M, Del Castillo A, Díaz S, Sánchez C. Domínguez-Gil A, et al. Clin Drug Investig. 2007;27(3):197-205. doi: 10.2165/00044011-200727030-00003. Clin Drug Investig. 2007. PMID: 17305414

2

Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium.

Selleslag D, Vogelaers D, Marbaix S. Selleslag D, et al. Acta Clin Belg. 2009 Sep-Oct;64(5):393-8. doi: 10.1179/acb.2009.065. Acta Clin Belg. 2009. PMID: 19999386

3

Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.

Ament AJ, Hübben MW, Verweij PE, de Groot R, Warris A, Donnelly JP, van 't Wout J, Severens JL. Ament AJ, et al. J Antimicrob Chemother. 2007 Aug;60(2):385-93. doi: 10.1093/jac/dkm196. Epub 2007 Jun 7. J Antimicrob Chemother. 2007. PMID: 17561501

4

Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany.

Jansen JP, Kern WV, Cornely OA, Karthaus M, Ruhnke M, Ullmann AJ, Resch A. Jansen JP, et al. Value Health. 2006 Jan-Feb;9(1):12-23. doi: 10.1111/j.1524-4733.2006.00076.x. Value Health. 2006. PMID: 16441520 Free article.

5

[Efficacies and clinical roles of new antifungal agents].

Tokimatsu I, Kadota J. Tokimatsu I, et al. Nihon Ishinkin Gakkai Zasshi. 2006;47(3):155-9. doi: 10.3314/jjmm.47.155. Nihon Ishinkin Gakkai Zasshi. 2006. PMID: 16940948 Free article. Review. Japanese.

6

Caspofungin versus liposomal amphotericin B for empirical therapy.

Danaher PJ. Danaher PJ. N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. N Engl J Med. 2005. PMID: 15675092 No abstract available.

7

Voriconazole: review of a broad spectrum triazole antifungal agent.

Kofla G, Ruhnke M. Kofla G, et al. Expert Opin Pharmacother. 2005 Jun;6(7):1215-29. doi: 10.1517/14656566.6.7.1215. Expert Opin Pharmacother. 2005. PMID: 15957974 Review.

8

[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.

[No authors listed] [No authors listed] Drug Ther Bull. 2004 Jan;42(1):5-8. Drug Ther Bull. 2004. PMID: 14768298

9

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.

Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S. Singh N, et al. Transplantation. 2006 Feb 15;81(3):320-6. doi: 10.1097/01.tp.0000202421.94822.f7. Transplantation. 2006. PMID: 16477215 Clinical Trial.

10

An update on the use of antifungal agents.

Martinez R. Martinez R. J Bras Pneumol. 2006 Sep-Oct;32(5):449-60. J Bras Pneumol. 2006. PMID: 17268750 Free article. Review. English, Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

191 results

Results by year